Listed

Cerus Corp

CERSNasdaqCIK 1020214HealthcareFiscal year ends Dec 31

Reports and events: 276 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Cerus Corp, Reports and events
FiledFormWhat it isAccession number
2026-07-3016:44 ET10-QQuarterly reportPeriod 2026-06-300001193125-26-326295
2026-07-3016:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-326093
2026-07-1016:35 ET8-K5.02 Departure or appointment of officers or directors0001020214-26-000015
2026-06-0816:20 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation0001193125-26-261794
2026-06-0316:17 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001193125-26-255488
2026-04-3017:05 ET10-QQuarterly reportPeriod 2026-03-310001193125-26-197777
2026-04-3016:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-197129
2026-04-2212:00 ETDEF 14AProxy statementPeriod 2026-04-220001020214-26-000011
2026-04-2116:21 ET8-K5.02 Departure or appointment of officers or directors0001020214-26-000007
2026-03-1617:18 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-26-108629
2026-03-0217:03 ET10-KAnnual reportPeriod 2025-12-310001193125-26-085678
2026-03-0216:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-085350
2026-01-2316:24 ET8-K5.02 Departure or appointment of officers or directors0001193125-26-021085
2026-01-1208:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-009824
2025-11-0617:01 ET10-QQuarterly reportPeriod 2025-09-300001193125-25-270039
2025-11-0616:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-25-269451
2025-08-0516:52 ET10-QQuarterly reportPeriod 2025-06-300000950170-25-103179
2025-08-0516:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-25-102976
2025-06-2316:32 ET8-K5.02 Departure or appointment of officers or directors0000950170-25-089029
2025-06-0913:39 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0000950170-25-083561
2025-05-0117:06 ET10-QQuarterly reportPeriod 2025-03-310000950170-25-061995
2025-05-0116:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-25-061808
2025-04-2312:33 ETDEF 14AProxy statementPeriod 2025-04-230000950170-25-057130
2025-02-2617:03 ET10-KAnnual reportPeriod 2024-12-310000950170-25-027906
2025-02-2016:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-25-024125
2025-02-0616:02 ET8-K5.02 Departure or appointment of officers or directors0000950170-25-015365
2025-01-1308:32 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-25-004588
2024-12-0916:59 ET8-K1.01 Entry into a material agreement0000950170-24-134618
2024-10-3116:11 ET10-QQuarterly reportPeriod 2024-09-300000950170-24-119535
2024-10-3016:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-118948
2024-10-1616:59 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-238169
2024-08-0116:54 ET10-QQuarterly reportPeriod 2024-06-300000950170-24-089390
2024-08-0116:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-089234
2024-07-0216:02 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000950170-24-080426
2024-06-1116:03 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0000950170-24-071855
2024-05-0217:02 ET10-QQuarterly reportPeriod 2024-03-310000950170-24-052296
2024-05-0216:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-052053
2024-04-2612:00 ETDEF 14AProxy statementPeriod 2024-04-250000950170-24-048801
2024-03-1908:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-24-033155
2024-03-0516:58 ET10-KAnnual reportPeriod 2023-12-310000950170-24-026195
2024-03-0516:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-025891
2024-01-0808:32 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-002726
2024-01-0516:05 ET8-K1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-003356
2023-11-0216:53 ET10-QQuarterly reportPeriod 2023-09-300000950170-23-058320
2023-11-0216:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-058154
2023-08-0316:24 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-038056
2023-08-0216:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-037123
2023-06-1209:39 ET8-K5.07 Shareholder vote results0000950170-23-027377
2023-05-0417:09 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-017965
2023-05-0416:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-017869

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.